Food and Drug Administration has issued 30 warning letters to telehealth companies for allegedly making false or misleading claims about compounded GLP-1 products on their websites, according to a March 3 announcement
Lengsfeld S, Hasenbohler F, Probst L, Baur F, Emara Y, Bathelt C, et al
Es enthlt keine GLP-1-Rezeptoragonisten und ist weder ein Arzneimittel noch ein Ersatz fr verschreibungspflichtige Medikamente
Unexpected Tooth Fractures or Cracks : Some individuals report teeth feeling more brittle or even breaking
Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
Final Thoughts Microdosing GLP-1 isnt right for everyone